UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2297) 2297
life sciences & biomedicine (2249) 2249
humans (2036) 2036
endocrinology & metabolism (1284) 1284
male (1045) 1045
diabetes mellitus, type 2 - drug therapy (977) 977
animals (967) 967
type 2 diabetes (966) 966
diabetes (892) 892
female (778) 778
glucose (750) 750
incretin (712) 712
insulin (665) 665
hypoglycemic agents - therapeutic use (648) 648
incretins (593) 593
blood glucose - metabolism (583) 583
glucagon (576) 576
middle aged (546) 546
insulin - metabolism (486) 486
adult (485) 485
incretins - therapeutic use (485) 485
incretins - metabolism (477) 477
dextrose (435) 435
insulin secretion (420) 420
biological and medical sciences (413) 413
glp-1 (412) 412
diabetes mellitus, type 2 - blood (402) 402
peptides (396) 396
diabetes mellitus, type 2 - metabolism (386) 386
obesity (366) 366
glucagon-like peptide 1 - metabolism (363) 363
insulin - blood (358) 358
insulin resistance (349) 349
treatment outcome (343) 343
dipeptidyl-peptidase iv inhibitors - therapeutic use (330) 330
diabetes mellitus (329) 329
aged (323) 323
glucagon-like peptide 1 (320) 320
glucagon-like peptide-1 (317) 317
medical sciences (308) 308
mice (299) 299
hypoglycemic agents - adverse effects (294) 294
analysis (293) 293
pharmacology & pharmacy (291) 291
blood glucose - drug effects (287) 287
internal medicine (278) 278
endocrine system (275) 275
digestive, oral, and skin physiology (272) 272
glucose metabolism (272) 272
hormones, hormone substitutes, and hormone antagonists (253) 253
medicine & public health (251) 251
physiological aspects (248) 248
endocrinopathies (247) 247
care and treatment (245) 245
risk factors (240) 240
diabetes therapy (237) 237
hypoglycemic agents - pharmacology (235) 235
liraglutide (234) 234
research (234) 234
endocrine pancreas. apud cells (232) 232
diabetes. impaired glucose tolerance (230) 230
physiology (230) 230
glucagon-like peptide 1 - blood (226) 226
glucagon-like peptide-1 receptor (225) 225
hypoglycemic agents (223) 223
hypoglycemic agents - administration & dosage (220) 220
diabetes mellitus, type 2 - physiopathology (219) 219
glucagon-like peptide 1 - analogs & derivatives (217) 217
incretins - pharmacology (216) 216
etiopathogenesis. screening. investigations. target tissue resistance (213) 213
glucagon-like peptide 1 - therapeutic use (213) 213
glucose - metabolism (212) 212
diabetes mellitus, type 2 - complications (210) 210
health aspects (210) 210
abridged index medicus (208) 208
glucose tolerance test (203) 203
hormones (198) 198
rats (194) 194
exenatide (193) 193
insulin-secreting cells - metabolism (193) 193
review (190) 190
drug therapy (186) 186
metabolism (186) 186
type 2 diabetes mellitus (186) 186
gastric inhibitory polypeptide - metabolism (184) 184
incretins - blood (181) 181
fundamental and applied biological sciences. psychology (177) 177
gip (177) 177
incretins - adverse effects (169) 169
hyperglycemia (168) 168
gastric inhibitory polypeptide - blood (164) 164
glucagon-like peptide 1 - pharmacology (163) 163
metabolic diseases (160) 160
cardiovascular system & cardiology (159) 159
glucagon-like peptide-1 receptor - agonists (159) 159
glycated hemoglobin a - metabolism (159) 159
incretin hormones (158) 158
drug therapy, combination (157) 157
time factors (154) 154
peptides - therapeutic use (151) 151
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2878) 2878
Japanese (22) 22
German (18) 18
French (16) 16
Spanish (14) 14
Russian (11) 11
Portuguese (10) 10
Czech (9) 9
Hungarian (8) 8
Chinese (4) 4
Polish (4) 4
Norwegian (3) 3
Danish (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
JAMA neurology, ISSN 2168-6149, 04/2019, Volume 76, Issue 4, pp. 420 - 429
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Exosomes - metabolism | Exenatide - therapeutic use | Phosphorylation | Signal Transduction | TOR Serine-Threonine Kinases - metabolism | Humans | Middle Aged | Male | Janus Kinases - metabolism | Parkinson Disease - drug therapy | Insulin Receptor Substrate Proteins - metabolism | MAP Kinase Signaling System | Brain - metabolism | Insulin - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Adult | Female | Aged | Neurons - metabolism | Parkinson Disease - metabolism | Incretins - therapeutic use | Proto-Oncogene Proteins c-akt - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | TOR protein | Drugs | Brain | Parkinson's disease | Glucagon | Pathogenesis | Parkinsons disease | Adhesion tests | Clinical trials | Antibodies | AKT protein | Statistical methods | Exosomes | Kinases | Cell adhesion & migration | Cell adhesion molecules | Proteins | Signal transduction | Vesicles | Randomization | Pathways | Cell adhesion | Secondary analysis | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Movement disorders | Tyrosine | Medical research | Human motion | Statistical analysis | Neurodegenerative diseases | Diabetes mellitus | MAP kinase | Rapamycin | Electrochemiluminescence | Insulin | Patients | Disease control | Substrates | Signaling | Insulin receptor substrate 1 | Molecular modelling | Biomarkers | Index Medicus | Abridged Index Medicus | Online First | Original Investigation | Research
Journal Article